Daniel C. Martin, Chief Commercial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 3,000 shares at $35.56 ($107K) on 2019-09-19, disclosed to the SEC on 2019-09-23.
Open-market sale of $107k DCPH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-12-14 | $27K | — | Filing → |
| DCPH | SELL | 2023-12-01 | $448K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $17K | — | Filing → |